Entest Group Inc

[JokersWild12]

Thanks Kbro,

Great to see the expansion of veterinary applications activating NR2F6 to address Exercise Induced Pulmonary Hemorrhage (EIPH) with race horses. Yet another large market(multi billions) along with their approach to treating canine and feline cancer and arthritis. Again multi billions.

Also good news to see a comment from Tom Ichim and that he is still involved with the company.

Note the following from the article:

"The number of drug developers is substantially smaller in veterinary medicine than in human medicine which could eventually lead to a strong presence in this market place for Zander."

Keep it coming. GL.